Results 131 to 140 of about 10,664 (186)

Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience. [PDF]

Rheumatology (Oxford)
Kavrul Kayaalp G, Çağlayan Ş, Ulu K, Türkmen Ş, Demirkan FG, Guliyeva V, Otar Yener G, Öztürk K, Demir F, Özdel S, Çakan M, Sönmez HE, Sözeri B, Aktay Ayaz N, PeRA Research Group .   +14 more
europepmc   +1 more source

Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]

Mater Today Bio
Yang L, Chen G, Lyu Z.
europepmc   +1 more source

Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0-16: a comprehensive analysis based on FAERS data. [PDF]

Pediatr Rheumatol Online J
Xiao P, Wei B, Zhang G, Zhang X, Wan H, Qi Y, Chen L, Huang Y, Liu J.   +8 more
europepmc   +1 more source

Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology. [PDF]

Front Cardiovasc Med
Wu H, Meng X, Li L, Zhang C.
europepmc   +1 more source

Pharmacologic management of renal involvement in monogenic autoinflammatory diseases. [PDF]

Eur J Med Res
Fayed A, Hegazy MT, Sota J, Gaggiano C, Ragab G.   +4 more
europepmc   +1 more source

Targeting NLRP3 Inflammasomes in Myocarditis: Potential Therapeutic Strategies and Clinical Translation. [PDF]

Scientifica (Cairo)
Retnowati FD, Halawa DR, Maayah ZH, Abdallah AM.   +3 more
europepmc   +1 more source

Anti-Inflammatory Therapies in Acute Coronary Syndromes-A Review of Immunological, Genetic, and Clinical Challenges for Precision Medicine. [PDF]

J Clin Med
Dudek M, Górniak N, Ostrowski M, Złotowska A, Gajewski P.   +4 more
europepmc   +1 more source

Model-Based Meta-Analysis With MonolixSuite: A Tutorial for Longitudinal Categorical and Continuous Data. [PDF]

CPT Pharmacometrics Syst Pharmacol
Bracis C, Taneja A, Lyauk YK, Barcomb H, de la Peña A, Cellière G.   +5 more
europepmc   +1 more source

Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy. [PDF]

JACC Asia
Zeng RX, Li S, Li JJ.
europepmc   +1 more source

Disproportionality Analysis of Adverse Events Associated with IL-1 Inhibitors in the FDA Adverse Event Reporting System (FAERS). [PDF]

Pharmaceuticals (Basel)
Lei J, Lou Z, Jiang Y, Cui Y, Li S, Hu J, Jing Y, Yang J.   +7 more
europepmc   +1 more source